PubRank

T H Rea

Author PubWeight™ 116.17‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991 8.85
2 Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions. Nature 1989 4.61
3 Cytokine patterns of immunologically mediated tissue damage. J Immunol 1992 2.72
4 Compartmentalization of a CD4+ T lymphocyte subpopulation in tuberculous pleuritis. J Immunol 1989 2.27
5 In situ demonstration of T lymphocyte subsets in granulomatous inflammation: leprosy, rhinoscleroma and sarcoidosis. Clin Exp Immunol 1983 2.21
6 T lymphocyte subsets in the skin lesions of patients with leprosy. J Am Acad Dermatol 1983 2.01
7 Immunosuppressive roles for IL-10 and IL-4 in human infection. In vitro modulation of T cell responses in leprosy. J Immunol 1993 2.00
8 Analysis of naturally occurring delayed-type hypersensitivity reactions in leprosy by in situ hybridization. J Exp Med 1989 1.82
9 Gamma delta T lymphocytes in human tuberculosis. J Infect Dis 1992 1.78
10 In situ identification of cells in human leprosy granulomas with monoclonal antibodies to interleukin 2 and its receptor. J Immunol 1984 1.74
11 Patterns of cytokine production by mycobacterium-reactive human T-cell clones. Infect Immun 1993 1.72
12 IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol 1994 1.65
13 Learning from lesions: patterns of tissue inflammation in leprosy. Proc Natl Acad Sci U S A 1988 1.62
14 In situ characterization of T lymphocyte subsets in the reactional states of leprosy. Clin Exp Immunol 1983 1.60
15 Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Nature 1986 1.56
16 Tumor necrosis factor production in patients with leprosy. Infect Immun 1992 1.55
17 Suppressor T lymphocytes from lepromatous leprosy skin lesions. J Immunol 1986 1.55
18 Primary dapsone-resistant Hansen's disease in California. Experience with over 100 Mycobacterium leprae isolates. Arch Dermatol 1990 1.42
19 T-cell release of granulysin contributes to host defense in leprosy. Nat Med 2001 1.40
20 Evidence for clonal selection of gamma/delta T cells in response to a human pathogen. J Exp Med 1991 1.38
21 IL-15, an immunomodulator of T cell responses in intracellular infection. J Immunol 1997 1.34
22 CD1 expression by dendritic cells in human leprosy lesions: correlation with effective host immunity. J Immunol 1999 1.32
23 A clinical trial of minocycline in lepromatous leprosy. BMJ 1992 1.32
24 Quantitation of the phenolic glycolipid of Mycobacterium leprae and relevance to glycolipid antigenemia in leprosy. J Infect Dis 1986 1.28
25 IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection. J Immunol 1999 1.24
26 Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 1995 1.23
27 Use of an artificial antigen containing the 3,6-di-O-methyl-beta-D-glucopyranosyl epitope for the serodiagnosis of leprosy. J Infect Dis 1984 1.16
28 Immunological significance of Mycobacterium leprae cell walls. Proc Natl Acad Sci U S A 1988 1.15
29 Serum angiotensin-converting enzyme in leprosy and coccidioidomycosis. Ann Intern Med 1977 1.14
30 Determinants of T cell reactivity to the Mycobacterium leprae GroES homologue. J Immunol 1997 1.14
31 In situ characterization of the cellular immune response in American cutaneous leishmaniasis. Clin Exp Immunol 1985 1.13
32 Evidence for human CD4+ T cells in the CD1-restricted repertoire: derivation of mycobacteria-reactive T cells from leprosy lesions. J Immunol 2000 1.12
33 In situ and in vitro characterization of the cellular immune response in erythema nodosum leprosum. J Immunol 1986 1.09
34 Expression of adhesion molecules in leprosy lesions. Infect Immun 1991 1.05
35 Variations in dinitrochlorobenzene responsivity in untreated leprosy: evidence of a beneficial role for anergy. Int J Lepr Other Mycobact Dis 1980 1.04
36 Lucio's phenomenon: a comparative histological study. Int J Lepr Other Mycobact Dis 1979 1.04
37 T-lymphocyte subsets in lymph nodes from homosexual men. JAMA 1983 1.01
38 Selection of T lymphocytes bearing limited T-cell receptor beta chains in the response to a human pathogen. Proc Natl Acad Sci U S A 1993 1.01
39 Interferon-gamma differentially regulates interleukin-12 and interleukin-10 production in leprosy. J Clin Invest 1997 1.01
40 Herpes gestationis in association with a hydatidiform mole. Immunopathologic studies. Arch Dermatol 1981 1.00
41 Altered distribution of B and T lymphocytes in lymph-nodes from homosexual men with Kaposi's sarcoma. Lancet 1983 0.98
42 Immunologic responses in patients with lepromatous leprosy. Arch Dermatol 1976 0.98
43 A role for IL-12 receptor expression and signal transduction in host defense in leprosy. J Immunol 2001 0.98
44 Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy. Int J Lepr Other Mycobact Dis 1994 0.97
45 Erythema nodosum leprosum in a general hospital. Arch Dermatol 1975 0.96
46 Current concepts in the immunology of leprosy. Arch Dermatol 1977 0.95
47 Serum and tissue lysozyme in leprosy. Infect Immun 1977 0.95
48 Tissue and blood T-lymphocyte subpopulations in erythema nodosum leprosum. Arch Dermatol 1985 0.95
49 A role for CD40-CD40 ligand interactions in the generation of type 1 cytokine responses in human leprosy. J Immunol 2000 0.93
50 Epidermal keratinocyte Ia expression, Langerhans cell hyperplasia and lymphocytic infiltration in skin lesions of leprosy. Clin Exp Immunol 1986 0.93
51 Treatment of chronic erythema nodosum leprosum with cyclosporine A produces clinical and immunohistologic remission. Int J Lepr Other Mycobact Dis 1987 0.93
52 Demonstration in situ of subsets of T-lymphocytes in sarcoidosis. Am J Dermatopathol 1984 0.91
53 Armadillo exposure among Mexican-born patients with lepromatous leprosy. J Infect Dis 1987 0.90
54 The histopathology of the spleen from a patient with lepromatous leprosy. Int J Lepr Other Mycobact Dis 1980 0.89
55 An in situ immunohistological study of Mitsuda reactions. Int J Lepr Other Mycobact Dis 1985 0.89
56 Kaposi's sarcoma in homosexual men: an immunohistochemical study. J Am Acad Dermatol 1983 0.87
57 Immunoperoxidase techniques applied to dermatopathology. J Cutan Pathol 1983 0.87
58 Lucio's phenomenon: an overview. Lepr Rev 1979 0.87
59 Suppressor cell activity and phenotypes in the blood or tissues of patients with leprosy. Clin Exp Immunol 1983 0.87
60 Dinitrochlorobenzene responsivity in disseminated coccidioidomycosis: an inverse correlation with complement-fixing antibody titers. J Invest Dermatol 1976 0.86
61 Immunopathology of leprosy granulomas. Springer Semin Immunopathol 1988 0.86
62 In situ identification of activated Ta1+ T lymphocytes in human leprosy skin lesions. Int J Lepr Other Mycobact Dis 1987 0.86
63 Serum macrophage migration inhibition activity in patients with leprosy. J Invest Dermatol 1982 0.86
64 IL-7 in the cell-mediated immune response to a human pathogen. J Immunol 1995 0.85
65 Limited T-cell receptor beta-chain diversity of a T-helper cell type 1-like response to Mycobacterium leprae. Infect Immun 1992 0.84
66 In situ localization of T lymphocytes in disseminated coccidioidomycosis. J Infect Dis 1985 0.84
67 Immunohistology of tuberculous adenitis in symptomatic HIV infection. Clin Exp Immunol 1988 0.83
68 In situ characterization of T lymphocyte subsets in leprosy granulomas. Int J Lepr Other Mycobact Dis 1982 0.83
69 Lepromin-induced suppressor cells in lepromatous leprosy. Cell Immunol 1987 0.83
70 Immunohistological evidence of lymphokine production and lymphocyte activation antigens in tuberculin reactions. Clin Exp Immunol 1987 0.82
71 Quantitative dinitrochlorobenzene (DNCB) responsivity and phytohemagglutinin (PHA) induced lymphocyte transformation in patients with lepromatous leprosy. Int J Lepr Other Mycobact Dis 1976 0.82
72 Lysozyme and angiotensin converting enzyme levels in experimental mycobacterial granulomas. J Pathol 1983 0.81
73 Ultrastructure of the dermal microvasculature in leprosy. Int J Lepr Other Mycobact Dis 1982 0.81
74 CD2 expression and function in lepromatous leprosy. Infect Immun 1989 0.81
75 Histocompatibility antigens in patients with leprosy. J Infect Dis 1976 0.81
76 Kaposi's sarcoma. Int J Dermatol 1983 0.81
77 The histology of erythema nodosum leprosum. Variant forms in New Guineans and other ethnic groups. Lepr Rev 1981 0.80
78 Lucio's phenomenon and diffuse nonnodular lepromatous leprosy. Arch Dermatol 1978 0.80
79 Immunoglobulin deposits in lepromatous leprosy skin. Presence of deposits in apparently uninvolved skin and occurrence of serum antiepithelial antibodies. Arch Dermatol 1975 0.79
80 Selective expansion of V delta 1 + T cells from leprosy skin lesions. J Invest Dermatol 1992 0.79
81 Lepromin skin testing in the classification of Hansen's disease in the United States. Am J Med Sci 1993 0.78
82 Role of granulysin in immunity to leprosy. Lepr Rev 2000 0.78
83 Serum angiotensin-converting enzyme, transcobalamin and lysozyme in normal and lepromatous armadillos. J Reticuloendothel Soc 1979 0.78
84 Peripheral blood T lymphocyte subsets in leprosy. Int J Lepr Other Mycobact Dis 1984 0.78
85 Silicone oil prevention of insensitive pressure ulcers. Int J Lepr Other Mycobact Dis 1997 0.78
86 Effect of cyclosporine A in erythema nodosum leprosum. J Immunol 1986 0.78
87 Demonstration of a subpopulation of Ia+ T-helper cells in mycosis fungoides and the Sézary syndrome. Am J Dermatopathol 1983 0.77
88 Immunocompetence and prognosis in patients with gynecologic cancer. Gynecol Oncol 1974 0.77
89 Delayed hypersensitivity in Graves' disease. J Clin Endocrinol Metab 1974 0.77
90 Immunopathologic demonstration of T lymphocyte subpopulations and interleukin 2 in granuloma annulare. Pediatr Dermatol 1984 0.77
91 HLA-DR antigens in tuberculoid and lepromatous leprosy. Lepr Rev 1980 0.77
92 Gamma delta T cells in leprosy lesions. Curr Top Microbiol Immunol 1991 0.76
93 Identification of cells lining pseudovascular spaces of benign pigmented nevi. Am J Dermatopathol 1984 0.75
94 Hypercalcemia and abnormal 1,25-dihydroxyvitamin D concentrations in leprosy. Am J Med 1988 0.75
95 Dinitrochlorobenzene responsivity: difference between patients with severe pulmonary coccidioidomycosis and patients with disseminated coccidioidomycosis. J Infect Dis 1979 0.75
96 Dermatology-important advances in clinical medicine: naturally acquired leprosy in animals. West J Med 1983 0.75
97 The anatomic site of vascular injury in mouse skin exposed to ultraviolet light. J Invest Dermatol 1968 0.75
98 In situ characterization of T lymphocyte subpopulations in leprosy in the mangabey monkey. Clin Exp Immunol 1986 0.75
99 T-lymphocyte clones from leprosy skin lesions. Lepr Rev 1986 0.75
100 Serologic survey for markers of hepatitis B infection in dermatologists. J Am Acad Dermatol 1985 0.75
101 Erythema nodosum leprosum in the absence of chemotherapy: a role for cell-mediated immunity. Lancet 1972 0.75
102 Dermal ultrastructure in leprosy. Arch Pathol Lab Med 1984 0.75
103 Synthesis and biological activity of new 2-substituted analogs of fluphenazine. J Med Chem 1976 0.75
104 B7-1, but not CD28, is crucial for the maintenance of the CD4+ T cell responses in human leprosy. J Immunol 1998 0.75
105 Herpes gestationis. Arch Dermatol 1978 0.75
106 Mechanisms of immunological unresponsiveness in the spectra of leprosy and leishmaniasis. Adv Exp Med Biol 1988 0.75
107 Leprosy: new insight into an ancient disease. J Am Acad Dermatol 1987 0.75
108 Granuloma annulare. Identification of cells in the cutaneous infiltrate by immunoperoxidase techniques. Arch Pathol Lab Med 1984 0.75
109 Serum pseudocholinesterase variants in Mexican-born patients with lepromatous leprosy. Int J Lepr Other Mycobact Dis 1979 0.75
110 Immunologic response in gynecologic malignancy as demonstrated by the delayed hypersensitivity reaction: clinical correlations. Am J Obstet Gynecol 1974 0.75
111 Melanoma. Associated antigens in benign melanocytic disorders. Int J Dermatol 1981 0.75
112 Letter: Comparative tuberculin reactions. JAMA 1974 0.75
113 Comparison of S-100 and OKT6 antisera in human skin. J Invest Dermatol 1984 0.75
114 Kaposi's sarcoma and autoimmune thrombocytopenia. Cancer Invest 1984 0.75
115 Apparently normal skin in lepromatous leprosy: histopathological findings. Arch Dermatol 1975 0.75
116 The 'butterfly' sign. A clue to generalized pruritus in a patient with chronic obstructive hepatobiliary disease. Arch Dermatol 1983 0.75
117 Quantitative enhancement of dinitrochlorobenzene responsivity in women receiving oral contraceptives. Arch Dermatol 1979 0.75
118 Absence of an apparent influence of long-term parenteral gold therapy upon dinitrochlorobenzene sensitization and responsivity to intradermal antigens. J Rheumatol 1980 0.75
119 Pseudosarcomatous angioplasia: atypical presentation of pyogenic granuloma. J Dermatol Surg Oncol 1983 0.75